This review by Oliver Philps provides an overview of GLP-1 agonists and where they fit in the treatment of diabetes, how the peptide drugs evolved over time to todays weight loss medications, and what to expect next...
Target gene expression was calculated using QuantStudio v1.3 (Applied Biosystems), normalized to the ACTB housekeeping gene using the C T method, and adjusted relative to the control condition
Ferrostatin-1 attenuates pathological angiogenesis in oxygen-induced retinopathy via inhibition of ferroptosis
IGlarLixi is a fixed-ratio combination of insulin glargine and lixisenatide, containing 100 U/mL of glargine and 33 lg/mL of lixisenatide in a 3-mL prefilled injection pen
People with B12 deficiency are good candidates for injections
Access this article Similar content being viewed by others Data Availability All the data collected for the study, together with the study protocol will be available following article publication from the corresponding author (email: [email protected]) upon reasonable request
